Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
Johnson & Johnson’s Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase…
Continue Reading